Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
68Ga-FAPI-46 PET/MRI in HCC
NCT05687747Phase 1Recruiting
- Sponsor
- National University Hospital
- Start
- Aug 2023
- Primary completion
- Aug 2025
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial, sponsored by National University Hospital. Primary endpoint: Sensitivity of FAPI-PET/MRI to detect intrahepatic HCC at 1 year. Started Aug 2023; status: recruiting.
Beyond the preview
Go deeper on NCT05687747.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05687747.